Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01252966 · ClinicalTrials.gov registry record · NA

Cognitive Training for Nicotine Dependence

A NA study of Tobacco Use Disorder and Nicotine Addiction, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
213
Enrollment target
1
Study location

NCT01252966 is a NA study of Tobacco Use Disorder and Nicotine Addiction that has completed, run by University of Pennsylvania. The registered enrollment target is 213 participants, below the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01252966, a NA study of Tobacco Use Disorder and Nicotine Addiction, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
213 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial tested the effects of a computerized (web-based) cognitive training intervention on smoking cessation. All participants received 8 weeks of standard nicotine patch therapy, smoking cessation counseling, and were randomized to 1 of 2 different training programs: cognitive training vs. control training.

Interventions

  • BEHAVIORAL Control training
  • BEHAVIORAL Cognitive Training

Study Locations (1)

Pennsylvania

  • Center for Interdiscplinary Research on Nicotine Addiction, University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2011-03
Est. Completion 2015-09
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01252966

The ClinicalTrials.gov registry entry for NCT01252966 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 236-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (10% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tobacco Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Control training is the first listed.

NCT01252966 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01252966 about?

NCT01252966 is a clinical study titled "Cognitive Training for Nicotine Dependence". This randomized clinical trial tested the effects of a computerized (web-based) cognitive training intervention on smoking cessation. All participants received 8 weeks of standard nicotine patch therapy, smoking cessation counseling, and were randomized to 1 of 2 different training programs: cognit...

What is the current status of trial NCT01252966?

This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2011-03. Estimated completion is 2015-09.

What conditions does trial NCT01252966 study?

This clinical trial studies the following conditions: Tobacco Use Disorder, Nicotine Addiction.

What interventions are being tested in trial NCT01252966?

The interventions under investigation include: Control training (BEHAVIORAL), Cognitive Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT01252966?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01252966 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.